Följ
Thomas Hofmarcher
Thomas Hofmarcher
IHE - The Swedish Institute for Health Economics
Verifierad e-postadress på ihe.se - Startsida
Titel
Citeras av
Citeras av
År
The cost of cancer in Europe 2018
T Hofmarcher, P Lindgren, N Wilking, B Jönsson
European Journal of Cancer 129, 41-49, 2020
2672020
The cost and burden of cancer in the European Union 1995–2014
B Jönsson, T Hofmarcher, P Lindgren, N Wilking
European Journal of Cancer 66, 162-170, 2016
1482016
The effect of education on poverty: A European perspective
T Hofmarcher
Economics of Education Review 83, 102124, 2021
912021
Comparator report on cancer in Europe 2019–disease burden, costs and access to medicines
T Hofmarcher, G Brådvik, P Lindgren
IHE-The Swedish Institute for Health Economics, 2019
57*2019
The societal costs of problem gambling in Sweden
T Hofmarcher, U Romild, J Spångberg, U Persson, A Håkansson
BMC public health 20, 1-14, 2020
552020
Comparator report on patient access to cancer medicines in Europe revisited
B Jönsson, T Hofmarcher, P Lindgren, N Wilking
412016
Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden
T Hofmarcher, S Borg
Journal of Medical Economics 18 (7), 492-501, 2015
332015
Cost effectiveness of implementing ESC guidelines for treatment of iron deficiency in heart failure in the Nordic countries
T Hofmarcher, D Cabrales Alin, C Linde
Scandinavian Cardiovascular Journal 52 (6), 348-355, 2018
132018
Access to high-quality oncology care across Europe
T Hofmarcher, B Jönsson, N Wilking
http://janssen-emea.com/sites/default/files/IHE_CC_Report_single_pages.pdf, 2014
13*2014
Specialization in same-sex and different-sex couples
T Hofmarcher, E Plug
Labour Economics 77, 101995, 2022
92022
The Porto European cancer research summit 2021
U Ringborg, A Berns, JE Celis, M Heitor, J Tabernero, J Schüz, ...
Molecular oncology 15 (10), 2507-2543, 2021
82021
1588MO_PR A comparative study on costs of cancer and access to medicines in Europe
N Wilking, G Brådvik, P Lindgren, C Svedman, B Jönsson, T Hofmarcher
Annals of Oncology 31, S1197, 2020
82020
The cost of cancers of the digestive system in Europe
T Hofmarcher, P Lindgren
IHE Report 6, 2020
72020
The burden and direct cost of cancer in Europe (EU-28).
NE Wilking, T Hofmarcher, P Lindgren, B Jönsson
Journal of Clinical Oncology 34 (15_suppl), 6618-6618, 2016
72016
Diagnosed but not treated: How to improve patient access to advanced NSCLC treatment in Europe
T Hofmarcher, P Lindgren, N Wilking
IHE Report/IHE Rapport, 2022
62022
Cancer i Sverige–Hur mycket beror på påverkbara riskfaktorer?
A Fridhammar, T Hofmarcher, S Persson
IHE Report/IHE Rapport, 2020
62020
Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in Europe
T Hofmarcher, P Lindgren, N Wilking
Journal of Cancer Policy 34, 100362, 2022
52022
The effect of paid vacation on health: evidence from Sweden
T Hofmarcher
Journal of Population Economics 34 (3), 929-967, 2021
42021
Samhällets kostnader för spelproblem i Sverige
T Hofmarcher, U Persson
IHE Report/IHE Rapport, 2020
42020
Comparator report on patient access to cancer medicines in Europe revisited–A UK perspective
B Jönsson, T Hofmarcher, P Lindgren, F Moen, N Wilking
IHE report 1, 2017
42017
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20